keyword
https://read.qxmd.com/read/38610791/the-beneficial-impact-of-pulmonary-rehabilitation-in-idiopathic-pulmonary-fibrosis-a-review-of-the-current-literature
#1
REVIEW
Stefano Sanduzzi Zamparelli, Carmen Lombardi, Claudio Candia, Paola Rebecca Iovine, Gaetano Rea, Michele Vitacca, Pasquale Ambrosino, Marialuisa Bocchino, Mauro Maniscalco
Idiopathic pulmonary fibrosis (IPF) is a chronic and irreversible fibrotic disease whose natural history is characterised by a progressive worsening of the pulmonary function, exertional dyspnoea, exercise intolerance, reduced physical activity, and health-related quality of life (HRQOL) impairment. Pulmonary rehabilitation (PR) is a comprehensive, multi-disciplinary programme that uses a combination of strength training, teaching, counselling, and behaviour modification techniques to reduce symptoms and optimise functional capacity in patients with chronic lung disease...
March 30, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38540667/the-role-of-lung-microbiome-in-fibrotic-interstitial-lung-disease-a-systematic-review
#2
REVIEW
Ruxandra Puiu, Nicoleta Stefania Motoc, Sergiu Lucaciu, Maria Victoria Ruta, Ruxandra-Mioara Rajnoveanu, Doina Adina Todea, Milena Adina Man
Interstitial Lung Disease (ILD) involves lung disorders marked by chronic inflammation and fibrosis. ILDs include pathologies like idiopathic pulmonary fibrosis (IPF), connective tissue disease-associated ILD (CTD-ILD), hypersensitivity pneumonitis (HP) or sarcoidosis. Existing data covers pathogenesis, diagnosis (especially using high-resolution computed tomography), and treatments like antifibrotic agents. Despite progress, ILD diagnosis and management remains challenging with significant morbidity and mortality...
February 20, 2024: Biomolecules
https://read.qxmd.com/read/38530061/covid-19-severity-and-mortality-in-veterans-with-chronic-lung-disease
#3
JOURNAL ARTICLE
Kristina Crothers, Scott V Adams, Aaron P Turner, Lisa Batten, Reyhaneh Nikzad, John R Kundzins, Vincent S Fan
INTRODUCTION: Chronic lung disease (CLD) has been associated with risk for more severe manifestations and death with COVID-19. However, few studies have evaluated the risk overall and by type of CLD for severity of COVID-19 outcomes in a US national cohort. METHODS: Using data from the Veterans Health Administration, we determined the risk associated with CLDs including COPD (mild/severe), asthma (mild/active/severe), idiopathic pulmonary fibrosis (IPF), sarcoidosis and other interstitial lung diseases (ILDs) for outcomes among veterans with SARS-CoV-2 positive tests between 3/1/2020-4/30/2021...
March 26, 2024: Annals of the American Thoracic Society
https://read.qxmd.com/read/38496302/a-novel-therapy-for-intractable-chronic-cough
#4
Matthew Bricknell, Chris Zi-Fan Zhao, Natasha Smallwood, Nicole Goh
Two cases of intractable chronic cough improved significantly with humidified high flow therapy (HHFT). A 59-year-old woman with Primary Sjogren's disease and interstitial lung disease, was trialled on a Fisher and Paykel myAIRVO™ system. She reported sustained benefits of uninterrupted sleep and increased socialization with tapering use of HHFT. A 67-year-old woman with idiopathic pulmonary fibrosis also benefited from the use of myAIRVO™. She had relentless cough with minimal movement, and nocturnal cough causing fragmented sleep...
March 2024: Respirology Case Reports
https://read.qxmd.com/read/38263093/the-association-between-adipokines-and-pulmonary-diseases-a-mendelian-randomization-study
#5
JOURNAL ARTICLE
Dongcai Wu, Ziyuan Wang, Keju Wang, Yuhan Wang, Tan Wang
BACKGROUND: The role of adipokines in the development of lung diseases is significant, yet their specific relationship with different lung diseases remains unclear. METHODS: In our research, we analyzed genetic variations associated with adipokines and various lung conditions such as interstitial lung disease, chronic obstructive pulmonary disease, asthma, lung cancer, sleep apnea, pneumonia, and tuberculosis, using data from public genome-wide studies. We employed Mendelian randomization techniques, including inverse variance weighting, weighted median, and MR-Egger regression methods, and conducted sensitivity checks to validate our findings...
January 23, 2024: BMC Pulmonary Medicine
https://read.qxmd.com/read/38190723/extracellular-matrix-as-a-driver-of-chronic-lung-diseases
#6
JOURNAL ARTICLE
Janette K Burgess, Daniel J Weiss, Gunilla Westergren-Thorsson, Jenny Wigen, Charlotte H Dean, Sharon Mumby, Andrew Bush, Ian M Adcock
The extracellular matrix (ECM) is not just a 3 dimensional scaffold that provides stable support for all cells in the lungs but is also an important component of chronic fibrotic airways, vascular, and interstitial diseases. It is a bioactive entity that is dynamically modulated during tissue homeostasis and disease, which controls structural and immune cell functions, drug responses, and which can release fragments that have biological activity and that can be used to monitor disease activity. There is a growing recognition of the importance of considering ECM changes in chronic airways, vascular, and interstitial diseases including (i) compositional changes, (ii) structural and organizational changes, and (iii) mechanical changes -and how these impact on disease pathogenesis...
January 8, 2024: American Journal of Respiratory Cell and Molecular Biology
https://read.qxmd.com/read/38094295/peptidylarginine-deiminase-2-citrullinates-mzb1-and-promotes-the-secretion-of-igm-and-iga
#7
JOURNAL ARTICLE
Benjamin Geary, Bo Sun, Ronak R Tilvawala, Leonard Barasa, Konstantin Tsoyi, Ivan O Rosas, Paul R Thompson, I-Cheng Ho
INTRODUCTION: MZB1 is an endoplasmic reticulum residential protein preferentially expressed in plasma cells, marginal zone and B1 B cells. Recent studies on murine B cells show that it interacts with the tail piece of IgM and IgA heavy chain and promotes the secretion of these two classes of immunoglobulin. However, its role in primary human B cells has yet to be determined and how its function is regulated is still unknown. The conversion of peptidylarginine to peptidylcitrulline, also known as citrullination, by peptidylarginine deiminases (PADs) can critically influence the function of proteins in immune cells, such as neutrophils and T cells; however, the role of PADs in B cells remains to be elucidated...
2023: Frontiers in Immunology
https://read.qxmd.com/read/38056846/-considerations-for-perioperative-management-of-patients-with-complicated-respiratory-dysfunction
#8
JOURNAL ARTICLE
Takashi Inoue, Masayuki Chida, Shota Umeda, Kenji Aruga, Hiromichi Inoue, Takahiro Nakajima, Sumiko Maeda, Muneo Minowa
This article describes the perioperative complications, perioperative risk assessment, and perioperative management of patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease, especially idiopathic pulmonary fibrosis( IPF), which are the leading diseases in respiratory dysfunction. In COPD, testing for forced expiratory volume during the first second and pulmonary diffusing capacity is important and an algorithm for testing has been presented by the Japanese Association for Chest Surgery...
September 2023: Kyobu Geka. the Japanese Journal of Thoracic Surgery
https://read.qxmd.com/read/37969279/cough-in-chronic-lung-disease-a-state-of-the-art-review
#9
REVIEW
Barnaby Hirons, Katherine Rhatigan, Harini Kesavan, Richard D Turner, Surinder S Birring, Peter S P Cho
Chronic cough (CC; ≥8 weeks in duration) is a common and burdensome feature of respiratory diseases. The understanding of cough has progressed significantly in recent years, albeit largely in refractory (unexplained) chronic cough (RCC) in the absence of other respiratory conditions. The prevalence of CC in respiratory diseases is poorly described, but estimates have been reported: asthma (8-58%), chronic obstructive pulmonary disease (COPD; 10-74%), bronchiectasis (82-98%), interstitial lung disease (ILD; 50-89%) and sarcoidosis (3-64%)...
October 31, 2023: Journal of Thoracic Disease
https://read.qxmd.com/read/37898765/ultrasound-evaluation-of-diaphragmatic-function-in-patients-with-idiopathic-pulmonary-fibrosis-a-retrospective-observational-study
#10
JOURNAL ARTICLE
Jules Milesi, Alain Boussuges, Paul Habert, Julien Bermudez, Martine Reynaud-Gaubert, Stéphane Delliaux, Fabienne Bregeon, Benjamin Coiffard
INTRODUCTION: The diaphragm function assessed by ultrasound has been well-studied in COPD, asthma, and intensive care. However, there are only a few studies on diffuse interstitial lung disease, while dyspnea and quality of life are major issues in the management that may depend on the diaphragm. METHODS: We retrospectively included idiopathic pulmonary fibrosis (IPF) patients followed in our center (Marseille, France) between January 2020 and February 2023 who underwent diaphragmatic ultrasound...
October 28, 2023: Respiratory Research
https://read.qxmd.com/read/37863339/influence-of-pulmonary-rehabilitation-on-symptoms-of-anxiety-and-depression-in-interstitial-lung-disease-a-systematic-review-of-randomized-controlled-trials
#11
REVIEW
Brandon Luu, Arnav Gupta, Nicholas Fabiano, Stanley Wong, Jess G Fiedorowicz, Lee Fidler, Risa Shorr, Marco Solmi
BACKGROUND: Interstitial lung diseases (ILDs) cause fibrosis of lung parenchyma, leading to impaired quality of life, dyspnea, and functional decline. Individuals with ILD experience a high prevalence of anxiety and depression. Recent research has demonstrated pulmonary rehabilitation (PR) alleviates symptoms of anxiety and depression in those with COPD. RESEARCH QUESTION: What is the influence of PR on symptoms of anxiety and depression in individuals with ILD? STUDY DESIGN: We conducted a PRISMA-2020-compliant systematic review of randomized controlled trials (RCTs) investigating PR's effect on anxiety and depression in patients with ILD...
2023: Respiratory Medicine
https://read.qxmd.com/read/37847730/five-repetition-sit-to-stand-test-responsiveness-and-minimal-important-difference-in-idiopathic-pulmonary-fibrosis
#12
JOURNAL ARTICLE
Puja Trivedi, Suhani Patel, George Edwards, Timothy Jenkins, William D-C Man, Claire M Nolan
RATIONALE: Standing from a sitting position is an important activity of daily living. The five-repetition sit-to-stand test (5STS) is a simple physical performance test that measures the fastest time taken to stand five times from a chair with arms folded. It can be measured in most healthcare settings, including the home where traditional field walking tests may not be possible. The 5STS has been validated in community-dwelling older adults and people with COPD, but data in idiopathic pulmonary fibrosis (IPF) are limited...
October 17, 2023: Annals of the American Thoracic Society
https://read.qxmd.com/read/37751461/prevalence-and-clinical-impacts-of-obstructive-sleep-apnea-in-patients-with-idiopathic-pulmonary-fibrosis-a-single-center-retrospective-study
#13
JOURNAL ARTICLE
Jae Ha Lee, Ji Hoon Jang, Jin Han Park, Sunggun Lee, Ji Yeon Kim, Junghae Ko, So Young Jung, Dae-Wook Kim, SungMin Hong, Hang-Jea Jang
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease with chronic, progressive lung fibrosis with a poor prognosis. Recent studies have reported a high prevalence of obstructive sleep apnea (OSA) in IPF patients and an association with poor prognosis. This study aimed to evaluate the prevalence, risk factors, and clinical effects on mortality of OSA in patients with IPF. METHODS: Clinical data were retrospectively analyzed in 167 patients with IPF at Haeundae-Paik Hospital, Republic of Korea...
2023: PloS One
https://read.qxmd.com/read/37736811/angiotensin-converting-enzyme-1-gene-polymorphisms-in-patients-with-systemic-sclerosis-associated-interstitial-lung-disease-a-single-centre-retrospective-observational-study
#14
JOURNAL ARTICLE
Boris Karanović, Marko Barešić, Ana Merkler Šorgić, Branimir Anić
Angiotensin-converting enzyme (ACE) 1 gene polymorphisms have been associated with vascular permeability, alveolar endothelial dysfunction and fibroblast proliferation and have been studied in pulmonary diseases such as COPD and idiopathic pulmonary fibrosis. Similar mechanisms of ACE 1 polymorphisms have been seen in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD). We are presenting a retrospective observational study in patients with SSc-ILD and analysing the association of ACE 1 gene polymorphisms (DD, II and ID) with the features of SSc, changes in pulmonary function tests (PFTs) and lung HRCT over three different periods of time (at the time of the diagnosis, 5 and 10 years after the diagnosis)...
September 22, 2023: Rheumatology International
https://read.qxmd.com/read/37608014/cohort-study-to-evaluate-prognostic-factors-in-idiopathic-pulmonary-fibrosis-patients-introduced-to-oxygen-therapy
#15
MULTICENTER STUDY
Kensuke Kataoka, Keishi Oda, Hajime Takizawa, Takashi Ogura, Atsushi Miyamoto, Yoshikazu Inoue, Shinobu Akagawa, Seishu Hashimoto, Tomoo Kishaba, Koji Sakamoto, Naoki Hamada, Kazuyoshi Kuwano, Masayuki Nakayama, Masahito Ebina, Noriyuki Enomoto, Yasunari Miyazaki, Kenichiro Atsumi, Shinyu Izumi, Yoshinori Tanino, Hiroshi Ishii, Hiroshi Ohnishi, Takafumi Suda, Yasuhiro Kondoh
While high-level evidence is lacking, numerous retrospective studies have depicted the value of supplemental oxygen in idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases, and its use should be encouraged where necessary. The clinical course and survival of patients with IPF who have been introduced to oxygen therapy is still not fully understood. The objective of this study was to clarify overall survival, factors associated with prognosis, and causes of death in IPF patients after the start of oxygen therapy...
August 22, 2023: Scientific Reports
https://read.qxmd.com/read/37574304/-association-between-chronic-lung-diseases-and-the-risk-of-lung-cancer-in-uk-biobank-observational-and-mendelian-randomization-analyses
#16
JOURNAL ARTICLE
J Zhang, Z M Ma, H Wang, Y T Fu, C Ji, M Zhu, H B Shen, H X Ma
Objective: To investigate the association between chronic lung diseases and the risk of lung cancer. Methods: Using UK Biobank (UKB) survey data, 472 397 participants who had not previously been diagnosed with cancer and whose self-reported sex was consistent with their genetic sex were studied. Information on the prevalence of previous chronic lung diseases, general demographic characteristics and the prevalence of lung cancer was collected using baseline questionnaires and national health system data. The multivariate Cox proportional risk regression model was used to analyze the association between four previous chronic lung diseases (asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and interstitial pulmonary disease) and the risk of lung cancer...
August 6, 2023: Zhonghua Yu Fang Yi Xue za Zhi [Chinese Journal of Preventive Medicine]
https://read.qxmd.com/read/37457568/changes-in-patient-reported-outcomes-in-patients-with-non-idiopathic-pulmonary-fibrosis-fibrotic-interstitial-lung-disease-and-progressive-pulmonary-fibrosis
#17
JOURNAL ARTICLE
Reoto Takei, Toshiaki Matsuda, Jun Fukihara, Hajime Sasano, Yasuhiko Yamano, Toshiki Yokoyama, Kensuke Kataoka, Tomoki Kimura, Atsushi Suzuki, Taiki Furukawa, Junya Fukuoka, Takeshi Johkoh, Yasuhiro Kondoh
BACKGROUND: Health-related quality of life (HRQoL) captures different aspects of the fibrotic interstitial lung disease (FILD) evaluation from the patient's perspective. However, little is known about how HRQoL changes in patients with non-idiopathic pulmonary fibrosis (IPF) FILD, especially in those with progressive pulmonary fibrosis (PPF). The aim of this study is to clarify whether HRQoL deteriorates in patients with non-IPF FILD and to evaluate the differences in the changes in HRQoL between those with and without PPF...
2023: Frontiers in Medicine
https://read.qxmd.com/read/37388961/early-detection-and-staging-of-lung-fibrosis-enabled-by-collagen-targeted-mri-protein-contrast-agent
#18
JOURNAL ARTICLE
Oluwatosin Y Ibhagui, Dongjun Li, Hongwei Han, Guangda Peng, Maureen L Meister, Zongxiang Gui, Jingjuan Qiao, Mani Salarian, Bin Dong, Yi Yuan, Yiting Xu, Hua Yang, Shanshan Tan, Ganesh Satyanarayana, Shenghui Xue, Ravi Chakra Turaga, Malvika Sharma, Yan Hai, Yuguang Meng, Khan Hekmatyar, Phillip Sun, Gabriel Sica, Xiangming Ji, Zhi-Ren Liu, Jenny J Yang
Chronic lung diseases, such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD), are major leading causes of death worldwide and are generally associated with poor prognoses. The heterogeneous distribution of collagen, mainly type I collagen associated with excessive collagen deposition, plays a pivotal role in the progressive remodeling of the lung parenchyma to chronic exertional dyspnea for both IPF and COPD. To address the pressing need for noninvasive early diagnosis and drug treatment monitoring of pulmonary fibrosis, we report the development of human collagen-targeted protein MRI contrast agent (hProCA32...
June 26, 2023: Chem Biomed Eng
https://read.qxmd.com/read/37269594/rev-erb%C3%AE-agonists-suppresses-tgf%C3%AE-1-induced-fibroblast-to-myofibroblast-transition-and-pro-fibrotic-phenotype-in-human-lung-fibroblasts
#19
JOURNAL ARTICLE
Chandrashekhar Prasad, Kameron Hahn, Santosh Kumar Duraisamy, Matthias A Salathe, Steven K Huang, Thomas P Burris, Isaac Kirubakaran Sundar
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by excessive scarring of the lungs that can lead to respiratory failure and death. Lungs of patients with IPF demonstrate excessive deposition of extracellular matrix (ECM) and an increased presence of pro-fibrotic mediators such as transforming growth factor-beta 1 (TGFβ1), which is a major driver of fibroblast-to-myofibroblast transition (FMT). Current literature supports that circadian clock dysfunction plays an essential role in the pathophysiology of various chronic inflammatory lung diseases such as asthma, chronic obstructive pulmonary disease, and IPF...
August 20, 2023: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/37264374/deep-learning-diagnostic-and-severity-stratification-for-interstitial-lung-diseases-and-chronic-obstructive-pulmonary-disease-in-digital-lung-auscultations-and-ultrasonography-clinical-protocol-for-an-observational-case-control-study
#20
JOURNAL ARTICLE
Johan N Siebert, Mary-Anne Hartley, Delphine S Courvoisier, Marlène Salamin, Laura Robotham, Jonathan Doenz, Constance Barazzone-Argiroffo, Alain Gervaix, Pierre-Olivier Bridevaux
BACKGROUND: Interstitial lung diseases (ILD), such as idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP), and chronic obstructive pulmonary disease (COPD) are severe, progressive pulmonary disorders with a poor prognosis. Prompt and accurate diagnosis is important to enable patients to receive appropriate care at the earliest possible stage to delay disease progression and prolong survival. Artificial intelligence-assisted lung auscultation and ultrasound (LUS) could constitute an alternative to conventional, subjective, operator-related methods for the accurate and earlier diagnosis of these diseases...
June 2, 2023: BMC Pulmonary Medicine
keyword
keyword
79553
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.